MEDX Holdings — Horizon Kinetics Medical ETF
Data updated: 2026-08-26
MEDX holds 33 securities. The top 10 make up 72.4% of net assets, led by Eli Lilly & (18.46%) and US Bank Mmda - Usbgfs 7 (9.19%). Health Care (90.4%) and Funds & ETFs (9.0%) are the largest sectors, and 77.4% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 101.83% of net asset value (99.83% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
MEDX Portfolio Holdings
33 holdings of Horizon Kinetics Medical ETF by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | Health Care | 18.46% | $3.52M |
| US Bank Mmda - Usbgfs 7 | USBGFS7 | Funds & ETFs | 9.19% | $1.75M |
| AbbVie Inc | ABBV | Health Care | 8.85% | $1.69M |
| Novartis AG | NVS | Health Care | 6.89% | $1.31M |
| Johnson & Johnson | JNJ | Health Care | 5.59% | $1.07M |
| Alkermes PLC | ALKS | Health Care | 5.53% | $1.05M |
| AstraZeneca PLC | AZN | Health Care | 4.98% | $950.94K |
| Ionis Pharmaceuticals Inc | IONS | Health Care | 4.53% | $864.58K |
| Bristol-Myers Squibb Co | BMY | Health Care | 4.42% | $843.79K |
| Merck & Co Inc | MRK | Health Care | 3.96% | $754.55K |
| Amgen Inc | AMGN | Health Care | 3.91% | $746.69K |
| Alnylam Pharmaceuticals Inc | ALNY | Health Care | 3.42% | $652.63K |
| Biogen Inc | BIIB | Health Care | 3.09% | $588.98K |
| Pfizer Inc | PFE | Health Care | 2.86% | $545.36K |
| Gsk PLC | GSK | Health Care | 2.71% | $516.13K |
| CRISPR Therapeutics AG | CRSP | Health Care | 2.64% | $503.30K |
| Regeneron Pharmaceuticals Inc | REGN | Health Care | 2.06% | $392.83K |
| Beam Therapeutics Inc | BEAM | Health Care | 1.51% | $287.88K |
| Galectin Therapeutics Inc | GALT | Health Care | 1.14% | $217.93K |
| Intellia Therapeutics Inc | NTLA | Health Care | 1.12% | $212.92K |
| Sandoz Group AG | SDZNY | Health Care | 0.80% | $152.02K |
| Replimune Group Inc | REPL | Health Care | 0.73% | $139.30K |
| Vanda Pharmaceuticals Inc | VNDA | Health Care | 0.73% | $138.61K |
| Haleon PLC | HLN | Consumer Staples | 0.60% | $114.84K |
| Lantern Pharma Inc | LTRN | Health Care | 0.55% | $104.93K |
| Editas Medicine Inc | EDIT | Health Care | 0.47% | $89.68K |
| GE HealthCare Technologies Inc | GEHC | Health Care | 0.28% | $53.77K |
| Bicycle Therapeutics PLC | BCYC | Health Care | 0.28% | $53.36K |
| Viatris Inc | VTRS | Health Care | 0.26% | $49.58K |
| Allogene Therapeutics Inc | ALLO | Health Care | 0.18% | $34.89K |
| Pacific Biosciences of California Inc | PACB | Health Care | 0.09% | $16.91K |
| Decoy Therapeutics Inc | DCOY | Health Care | 0.00% | $149 |
| Pathos AI Inc | 2368714D | Unknown | 0.00% | $0 |
MEDX Sector Allocation
Horizon Kinetics Medical ETF holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 90.4% | 30 |
| Funds & ETFs | 9.0% | 1 |
| Consumer Staples | 0.6% | 1 |
| Unknown | 0.0% | 1 |
MEDX Country Allocation
Where Horizon Kinetics Medical ETF's holdings are domiciled, by percentage of net assets (largest 4).
| Country | % of net assets |
|---|---|
| United States | 77.4% |
| Switzerland | 10.3% |
| United Kingdom | 8.6% |
| Ireland | 5.5% |
MEDX Portfolio Allocation
Asset-class allocation of Horizon Kinetics Medical ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 92.6% |
| Cash & Equivalents | 9.2% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.